Paying 25× for a business growing organic sales ~1% — multiple de-rating if the cycle or margins slip
One-line thesis. ITW is a genuinely elite operator — 26.5% operating margins, ~25% ROIC, a 60-plus-year dividend record and the famous "ITW Business Model" — but it is a mature, cyclically exposed, ~1%-organic-growth multi-industrial trading at ~25× earnings and 18.7× EV/EBITDA, i.e. a premium price for a low-growth compounder. Quality is not in question; the price you pay for it is. Watch for a better entry.
◆ Synthos call — HoldITW is a solid business largely reflected at ~$265 — fine to keep, no reason to chase; it gets interesting again below ~$225.
Downside Risk (lower = safer)
5/10 · Moderate
Investment-grade, beta ~1.0, low drawdown — but 25× earnings & 18.7× EV/EBITDA on ~1% revenue growth, and net-debt/EBITDA 1.8× with negative tangible equity.
Growth Quality
6/10 · High
Elite margins (26.5% op) & 25% ROIC, but ~4% forward revenue and ~6% EPS CAGR — quality without much growth.
Exponential Potential
2/10 · Low
A $78B mature, decelerating multi-industrial in cyclical end-markets; essentially zero multibagger optionality.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 14%/yrTo justify today’s $273, earnings would have to compound roughly 14% a year for 10 years (9% discount rate). Analysts forecast ~5%/yr, so the market is pricing in MORE than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Illinois Tool Works makes the unglamorous but essential stuff that keeps factories, restaurants, cars and construction sites running — fasteners, welding gear, commercial kitchen equipment, testing machines, adhesives. Seven business segments, none flashy, all profitable. It's one of the best-run industrial companies in America and has raised its dividend for decades.
The catch: the business barely grows. Sales rose less than 1% last year, and even the company's own forecast is for 2–4% growth. Meanwhile the stock costs about 25 times earnings — a price you'd normally pay for a faster grower. So you're paying a premium for quality and reliability, not for growth. Our verdict is Watch: a wonderful company, but not obviously cheap, and the stock has lagged the market badly (up ~7% over the past year while the S&P 500 rose ~21%).
Here's what our three scores mean in everyday terms:
Downside Risk 5/10 (middle of the road). Financially solid and its stock doesn't swing wildly, but the price already assumes everything goes right, so a stumble would hurt.
Growth Quality 6/10 (good, not great). Superb profitability and returns — but very little actual growth, which drags the score down.
Exponential Potential 2/10 (low). This is a big, mature, slow-growing company. Don't expect it to double any time soon; that's not what it is.
The one big worry: you're paying up for a business whose sales grow ~1%. If the economy softens or margins stop expanding, the stock's rich multiple has room to fall.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLI (sector)), set to 100 a year ago
Solid = ITW · dashed = S&P 500 · dotted = XLI (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$272.76
Market cap$78B
P/E trailing12×
P/E FY26E / FY27E24× / 22×
EV / Sales5.4×
EV / EBITDA18.7×
Gross margin44.1%
Net margin19.3%
Dividend yield2.36%
Beta1.011
52-wk range$241 – $300
RSI(14)72
50 / 200-DMA$258 / $260
12-mo return+7% (SPY +21%)
Street target$274 ($254–$301)
Analyst grades6 Buy · 13 Hold · 9 Sell
FMP ratingB
Next earnings2026-08-05
What the experts actually said 0 traceable claims on ITW · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Illinois Tool Works (NYSE: ITW), founded 1912 and headquartered in Glenview, Illinois, is a ~$16B-revenue global multi-industrial manufacturer run on the decentralized "ITW Business Model" — a portfolio of highly focused, high-margin niche businesses using an 80/20 (focus on the vital few products/customers) operating discipline. It reports in seven segments. Fiscal year ends December 31. CEO Christopher A. O'Herlihy; ~43,000–44,000 employees.
Revenue mix (FY2025, from filings):
By segment: Automotive OEM $3.29B (20%) · Test & Measurement / Electronics $2.83B (18%) · Food Equipment $2.70B (17%) · Welding $1.89B (12%) · Construction Products $1.82B (11%) · Specialty Products $1.78B (11%) · Polymers & Fluids $1.77B (11%). Well diversified — no segment over ~20%.
By geography: North America $8.48B + United States (reported separately) $7.40B → the Americas dominate; Europe $4.16B, Asia Pacific $3.08B, South America $0.32B. Roughly half of revenue is international, giving real FX sensitivity (FX added ~3.9% to Q1'26 revenue).
The end-markets — autos, construction, general industrial capex, commercial food service — are cyclical, which is the structural feature to keep front of mind: ITW's quality shows up in how well it defends margins through cycles, not in secular growth.
2. The expert thesis — why the panel is bullish (traceable)
There is no expert coverage of ITW in the Synthos knowledge base.total_claims = 0, net_bullish_voices = 0. None of the tracked expert voices (the panel that drives our high-conviction names) has an on-record, traceable claim on ITW.
That means this note carries no conviction score and cites zero claim_ids — because there are none to cite, and fabricating conviction is against the house standard. The verdict below is entirely fundamentals- and quant-driven: reported financials, analyst consensus estimates (labeled as estimates), valuation, technicals and management's own guidance. Read the scores in §3 as the whole of the argument, not as a distillation of expert opinion. Where we would normally lean on the panel to resolve the bull/bear tension, here we lean only on the numbers — and the numbers say great business, full price, little growth.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
5 · Moderate
Beta ~1.0, shallow drawdown (−9% off highs), investment-grade, ~14× interest coverage — but 25× EPS / 18.7× EV/EBITDA on ~1% organic growth is priced for perfection, net-debt/EBITDA 1.8×, and book equity is tiny (negative tangible equity from buybacks).
Growth Quality
6 · Good
Elite operations — 44% gross, 26.5% operating margin, ~25% ROIC, ~97% ROE, high FCF conversion — but only ~4% forward revenue and ~6% EPS CAGR. Quality without growth caps the score.
Exponential Potential
2 · Low
A mature $78B multi-industrial in cyclical markets; growth decelerating (organic +0.4% in Q1'26); essentially no multibagger optionality.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
Estimates roughly hit — FY26E EPS $11.31, FY27E $12.12; a high-quality but low-growth compounder earns a ~22× multiple on FY27E EPS.
~$265 (−3%)
Bear
Industrial/cyclical downturn, autos & construction soften, margin expansion stalls; FY27E EPS slips to ~$11 and the multiple de-rates toward its historical low-teens/high-teens on cyclicality → ~17×.
~$205 (−25%)
Synthos fair value = the base case, ~$265 (−3%), with the full $205–$320 span as the honest range. This sits just below the Street's $274 consensus — appropriate, since the Street itself rates ITW a Hold (6 Buy / 13 Hold / 9 Sell) and its consensus target implies essentially no upside from here. The distribution is skewed: limited upside (already a premium multiple) against real cyclical downside. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). ITW is a high-quality compounder with essentially no exponential profile:
Forward growth: revenue CAGR FY25→FY29E ~3.6% ($16.0B → $18.5B); EPS CAGR ~6.5% ($10.52 → $13.51E), with the gap over revenue coming from buybacks and modest margin expansion — not unit growth.
Acceleration (the 2nd derivative) is flat-to-negative: organic revenue growth was +0.4% in Q1'26; management guides FY26 organic to just 1–3%. This is a mature, GDP-ish grower; there is no inflection to ride.
Room to run: at $78B in a set of cyclical, share-mature niche markets, there is no large untapped TAM that could drive a step-change. ITW's playbook is margin/returns optimization on a slow-growing base, not category expansion.
Reinvestment runway: deliberately low capex (~$0.42B/yr, ~2.6% of sales) — ITW returns cash rather than reinvests for growth (~$1.5B/yr buyback + ~$1.8B dividend). That's rational capital allocation, but it is the signature of a mature compounder, not an exponential.
Exponential Potential: Low (2/10). Own ITW, if at all, for durable margins, dividends and low volatility — never for a fast multibagger. A small, accelerating name would score far higher here; ITW is the honest opposite end of that scale.
Revenue: FY25 $16.04B, +0.9% (FY24 $15.90B; FY23 $16.11B) — essentially flat for three years. Q1'26 $4.02B, +4.6% reported but only +0.4% organic (FX +3.9%, acquisitions +0.3%).
Margins (elite): gross 44.1% TTM, operating margin 26.5% (25.4% in Q1'26, +60 bps YoY), net 19.3% TTM. Best-in-class for a diversified industrial.
Earnings: FY25 net income $3.07B, EPS $10.52 (diluted $10.49). Note the optics: FY24 EPS was $11.75, but that year included ~$0.4B+ of one-time non-operating gains (see the FY24 non-operating line and the elevated Q3'24 print) — FY25's $10.52 is the cleaner run-rate, so "EPS down YoY" overstates any deterioration.
Returns on capital (the crown jewel):ROIC ~24.7%, ROE ~97% (flattered by a thin equity base), return on capital employed ~39%. This is why the market pays up.
Cash flow: FY25 operating CF $3.13B, capex −$0.42B, FCF $2.71B (FCF yield ~3.5%). High conversion; management guides FY26 FCF to exceed 100% of net income.
Balance sheet: total debt $8.97B, net debt $8.12B, net-debt/EBITDA ~1.8× — investment-grade and easily serviced (~14× interest coverage), but note total equity is only ~$3.2B and tangible book is negative (−$8.4/share) because decades of buybacks have shrunk equity. That inflates ROE and is worth understanding, though it is not a solvency concern at this coverage.
6. Valuation — priced in or room?
ITW is not cheap. Trailing 25× EPS, 5.4× EV/sales, 18.7× EV/EBITDA, ~24× price/FCF. On forward consensus the multiple compresses only slowly because growth is slow: 24× FY26E → 22.5× FY27E → ~20× FY29E. For a business compounding EPS ~6%/yr, a mid-20s P/E is a premium-for-quality multiple, not a value entry — the PEG is unfavorable. FMP's letter rating (B, with P/E and P/B sub-scores of 2 and 1) flags the same richness. Street targets (context): consensus $274.29 (high $301, low $254) — essentially the current price, i.e. the Street sees no margin of safety either, hence the Hold consensus. Our base FV (~$265) sits marginally below that, reflecting the skew: you're paying a full multiple for ~1% organic growth, so the risk/reward is roughly symmetric-to-negative from here. A price in the low-$200s (≈18–19× FY27E) would be a materially more attractive entry.
7. Technicals (from the tech block)
Trend: mildly up. $272.76 sits above the 50-DMA ($257.7) and 200-DMA ($260.2), and the 50 is now back above the 200 — a constructive posture, but a shallow one.
Location:−9.0% off the 52-week high ($299.60), +13% off the 52-week low ($241.07); max drawdown from peak only −9% (low-volatility name).
Momentum:RSI(14) 71.7 — overbought (>70). MACD +4.2 (positive). The overbought reading is a near-term caution flag against chasing at $273; a pullback would be a healthier entry.
Relative strength (the tell): ITW +6.9% 12-mo vs SPY +20.6% and QQQ +30.3% — a persistent laggard versus both the market and tech. +4.7% 3-mo vs SPY +13.7%. This is the chart of a defensive, slow-grower, not a leader.
Read: technicals are benign but unexciting — an in-uptrend, low-beta name that has badly trailed the index, currently overbought. No urgency to buy; if anything, wait for RSI to cool.
8. Moat & competitive position
ITW's moat is operational, not secular: the decentralized "ITW Business Model" plus 80/20 discipline delivers durable 26.5% operating margins and ~25% ROIC that most industrials cannot match, across 7 diversified niches where ITW often holds patented, spec'd-in, high-share positions with sticky customers. The famous "enterprise initiatives" continue to add ~100 bps/yr of margin. But the moat protects profitability, not growth — the end-markets (auto OEM, construction, general industrial capex, food service) are cyclical and mature, so the moat is best understood as a margin-and-returns fortress, not a growth engine.
Peer set (market cap, from FMP): Cummins $91B, CSX $91B, Johnson Controls $86B, Canadian Pacific KC $78B, Emerson $78B, TransDigm $75B, Ametek $54B, Thomson Reuters $39B, Roper $37B, Howmet $108B. Within diversified/multi-industrials, ITW screens as top-decile on margin and ROIC but bottom-quartile on organic growth — the exact quality-vs-growth tradeoff this note keeps flagging.
9. Management, capital allocation & guidance
Capital allocation: textbook mature-compounder — ~$1.5B/yr buyback (guided again for FY26), ~$1.8B/yr dividend (yield 2.36%, payout ~58%, a multi-decade raiser), deliberately low capex (~2.6% of sales), bolt-on M&A only. Rational for a ~25%-ROIC business with limited organic reinvestment runway.
Insider activity: the recent Form 4s are routine — RSU awards and a small director purchase (director Scanlon bought 806 shares at ~$248 on 2026-06-02) plus new-officer Form 3 filings. No cluster of alarming discretionary selling in the sampled window; the director open-market buy is a mild positive.
Management's own guidance (half-weighted — their own book). From the Q1'26 earnings release (SEC 8-K, filed 2026-04-30), management raised full-year 2026 GAAP EPS guidance by $0.10 to $11.10–$11.50 (~8% growth at the midpoint), and reaffirmed: total revenue growth 2–4%, organic growth 1–3%, all seven segments delivering positive organic growth and margin expansion, operating margin 26.5–27.5% (~100 bps improvement, ~100 bps from enterprise initiatives), free cash flow >100% of net income, ~$1.5B of buybacks, and a 23–24% tax rate. Treat as management's self-interested framing, but it is specific, quantified and consistent with the estimates — and it explicitly confirms the low-single-digit growth profile at the heart of our Watch call.
10. Catalysts & what to watch
Next earnings: 2026-07-29 (Q2'26; Street EPS $2.80, revenue ~$4.19B). The key line: organic revenue growth (can it move above the Q1 +0.4%?) and operating margin vs the 26.5–27.5% full-year guide.
Cyclical capex signals: Welding and Test & Measurement/Electronics were the Q1 bright spots (organic +6% and +5%) — sustained strength there is the bull's evidence; Auto OEM and Specialty were negative.
Margin/enterprise initiatives: continued ~100 bps/yr expansion is the main EPS lever given flat volume.
FX: ~half of sales are ex-US; a strong dollar reversing would be a tailwind (FX added ~3.9% in Q1'26).
Capital return: dividend raise (typically declared H2) and buyback pace.
Thesis tripwires (what would change the call): organic growth turning negative for two quarters (bearish); or a de-rating to ~18× FY27E / low-$200s (would flip us toward Buy — Tactical on quality-at-a-fair-price); or a durable step-up in organic growth above mid-single-digits (would raise the Growth and Exponential scores).
11. Key risks
Valuation / de-rating (the primary risk): ~25× EPS and 18.7× EV/EBITDA for ~1% organic growth leaves little margin of safety; any cyclical or margin disappointment can compress the multiple toward its historical mean.
Cyclicality: auto OEM, construction and industrial capex are economically sensitive; a downturn hits volume and, with high fixed-cost leverage, margins.
Growth scarcity: the structural issue — a great business that simply doesn't grow much; total return depends heavily on multiple stability + buyback + dividend, not organic compounding.
FX translation: ~half of revenue is international; dollar strength is a headwind (and flattered Q1'26 the other way).
Thin/negative tangible equity: buyback-driven; not a solvency issue at ~14× coverage, but it flatters ROE and leaves less balance-sheet cushion than the returns suggest.
No expert coverage: unlike our conviction names, there is no independent expert panel corroborating (or challenging) the thesis here — the call rests solely on fundamentals and quant.
12. Verdict, position sizing & monitoring
Watch. ITW is a genuinely elite operator — 26.5% operating margins, ~25% ROIC, best-in-class capital discipline and a multi-decade dividend record — and nothing here is a knock on business quality. The problem is strictly price for growth: ~25× trailing / ~24× forward earnings and 18.7× EV/EBITDA for a mature, cyclical business growing organic revenue ~1% and EPS ~6%. The Street agrees (Hold; target ≈ current price), the stock has lagged the index badly for a year, and it's currently overbought. That combination argues for patience, not purchase, at $273.
Sizing: if already owned as a low-beta, dividend-quality anchor, a modest ~1–2% weight is defensible; it is not a growth or exponential allocation. New money is better deployed on a pullback.
What would move us to Buy: a de-rating into the low-$200s (≈18–19× FY27E) — quality-at-a-fair-price — or evidence of a durable step-up in organic growth. Either flips the risk/reward.
Monitoring: re-score each earnings print (next 2026-07-29); watch organic growth, margin vs the 26.5–27.5% guide, and the multiple. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $272.76.
Single biggest risk: paying a premium multiple for ~1% organic growth — the de-rating risk if the cycle or margin story disappoints.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — ITW has no expert coverage in the Synthos knowledge base. No claim_ids are cited because none exist; per house standard we did not fabricate conviction. This is a fundamentals- and quant-driven note.
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from the SEC 8-K earnings release filed 2026-04-30. Forward figures are analyst consensus (FMP) or company guidance, labeled as estimates.
Management caveat: the §9 guidance is management's own, self-interested framing, half-weighted by design.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").